Nuvation Bio
NUVB
NUVB
230 hedge funds and large institutions have $944M invested in Nuvation Bio in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.92% more ownership
Funds ownership: 61.7% → 63.62% (+1.9%)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
50% less capital invested
Capital invested by funds: $1.89B → $944M (-$951M)
Holders
230
Holding in Top 10
5
Calls
$5.27M
Puts
$3.64M
Top Buyers
| 1 | +$25.3M | |
| 2 | +$15.9M | |
| 3 | +$10.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.8M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$8.64M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$14.2M | |
| 3 | -$13.4M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$13M |
| 5 |
SCP
SymBiosis Capital Partners
Bentonville,
Arkansas
|
-$11.2M |
